Pausing of RNA polymerase II (Pol II) during early transcription, mediated by the negative elongation factor (NELF) complex, allows cells to coordinate and appropriately respond to signals by modulating the rate of transcriptional pause release. Promoter proximal enrichment of Pol II occurs at uterine genes relevant to reproductive biology; thus, we hypothesized that pausing might impact endometrial response by coordinating hormonal signals involved in establishing and maintaining pregnancy. We deleted the NELF-B subunit in the mouse uterus using PgrCre (NELF-B UtcKO). Resulting females were infertile. Uterine response to the initial decidual stimulus of NELF-B UtcKO was similar to that of control mice; however, subsequent full decidual response was not observed. Cultured NELF-B UtcKO stromal cells exhibited perturbances in extracellular matrix components and also expressed elevated levels of the decidual prolactin Prl8a2, as well as altered levels of transcripts encoding enzymes involved in prostaglandin synthesis and metabolism. Because endometrial stromal cell decidualization is also critical to human reproductive health and fertility, we used small interfering to suppress NELF-B or NELF-E subunits in cultured human endometrial stromal cells, which inhibited decidualization, as reflected by the impaired induction of decidual markers PRL and IGFBP1. Overall, our study indicates NELF-mediated pausing is essential to coordinate endometrial responses and that disruption impairs uterine decidual development during pregnancy.
Pausing of RNA polymerase II (Pol II) during early transcriptional elongation is an important rate-limiting step in which an engaged transcription complex pauses near some transcription start sites (1, 2) . The NELF complex mediates the pausing and is composed of 4 subunits (A, B, C/D, and E) (3) . Cells are able to coordinate and appropriately respond to different signals by modulating the rate of pause release through recruitment of pTEF-b, which phosphorylates NELF and serine 2 of the Pol II amino terminal domain, leading to disassociation of the NELF complex and allowing RNA elongation (1) . Phenotypes resulting from deletion of NELFA or NELFC/D in animal models have not yet been described. Reported preweaning lethality in a NELF-E deletion mouse model (4) , and embryonic lethality of mice with disrupted pausing due to deletion of the NELF-B subunit emphasize the critical roles of this mechanism in biologic processes but also hinder study of postembryonic roles for this activity (5) .
ABBREVIATIONS: BAD, BCL2-associated agonist of cell death; Bmp, bone morphogenetic protein; Ccn, Cyclin; Cdk, cyclin-dependent kinase; Col, collagen; DEG, differentially expressed gene; Des, Desmin; ECM, extracellular matrix; Edn, endothelin; EPC, E 2 + P 4 + cAMP; FDR, false discovery rate; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; hESC, human endometrial stromal cells; Hsd, hydroxysteroid dehydrogenase; IGFBP, insulin-like growth factor binding protein; Itg, integrin; Krt, keratin; Lama, laminin; Mad2l, MAD2 mitotic arrest deficient-like; Mki67, monoclonal antibody Ki 67; Mmp, matrix metallopeptidase; NELF, negative elongation factor; NELF-B UtcKO, NELF-B uterine conditional knockout; P 4 , progesterone; PGR, progesterone receptor; PolII, RNA polymerase II; PRL, prolactin; Ptgs2, prostaglandin-endoperoxide synthase 2; siNELF, small interfering RNA targeting NELF; siNT, small interfering RNA with nontargeting control; siRNA, small interfering RNA; Wnt, wingless-type MMTV integration site family; WT, wild type During pregnancy, the uterus responds to diverse signals that occur in critical temporal windows. The ovarian hormones estrogen (E 2 ) and progesterone (P 4 ) fluctuate as oocytes mature and are ovulated, fertilized in the oviduct, and then implanted in the uterine wall (6) . All uterine cells contain estrogen receptor a (7) , whereas the levels of progesterone receptor (PGR) vary in different uterine cell types according to the levels of E 2 (6) . Massive uterine tissue remodeling occurs during pregnancy to support the growing embryo and placenta (8) . Uterine stromal cells undergo a process called decidualization that is driven by rising levels of ovarian hormones coupled with signals initiated by contact with the embryo as it interacts with and invades the uterine wall. These signals induce decidualization, a process by which stromal cells change from fibroblast-like cells to rounded cells via alterations in their extracellular matrix components; decidualized stromal cells secrete prolactins and synthesize prostaglandins. Perturbations in many of these key uterine functions are major contributors to pathologies, including leiomyoma, preeclampsia, endometriosis, endometrial hyperplasia, and cancer, that impact women's health (6, 9) . We previously performed Pol II chromatin immunoprecipitation sequencing on estrogen-stimulated mouse uterine tissue and analyzed Pol II accumulation near transcription start sites (10) . These data revealed promoter proximal enrichment of Pol II at a number of genes relevant to reproductive biology; thus, we hypothesized that transcriptional pausing might impact endometrial response to hormonal signals and endometrial remodeling during pregnancy.
Here we used a conditional knockout approach to disrupt the transcriptional pausing complex in uterine cells by deleting the NELF-B subunit using PgrCre (NELF-B UtcKO). Resulting females were infertile; therefore, we characterized the endometrial functions linked to hormonal actions that are critical for establishing and maintaining pregnancy.
MATERIALS AND METHODS

Animals
PgrCre+ mice (11) were bred with mice with loxP sites flanking the first 4 exons of Nelfb (12). Breeding PgrCre + ; Nelfb f/f 3 Nelfb f/2 resulted in PgrCre + ; Nelfb f/f or PgrCre+; Nelfb f/2 females, called NELF-B UtcKO. NELF-B f/f and f/2 females were used as controls and are called wild type (WT). Ear biopsies were sent to Transnetyx (Cordova, TN, USA) for genotyping.
Breeding trial to assess fertility WT males were continuously bred with WT or NELF-B UtcKO females for 6 mo. Males were switched to the opposite genotype female 3 mo into the study. Average litters per dam and pups per litter were calculated.
Vaginal cytology and superovulation
Vaginal cytology was evaluated each morning for 12 d by washing the exterior of the vagina with 50 ml of normal saline, drying each sample on a glass slide, and staining with Giemsa. Slides were evaluated and assigned to the appropriate stage of the estrous cycle. For superovulation, females were injected with 3.25 IU of pregnant mare serum gonadotropin in the afternoon and then injected 48 h later with 2.2 IU of human chorionic gonadotropin. Oocytes were collected 16 h later from the bursa and counted.
Decidualization assay
Adult females (.10 wk old) were ovariectomized, rested for 10-14 d to clear ovarian hormones, and then treated daily for 3 d with E 2 (100 ng in 100 ml sesame oil, s.c.). Two days after the last E 2 injection, mice were treated daily with P 4 (1 mg) + E 2 (6.7 ng) in 100 ml sesame oil injected subcutaneously. On the third day of P 4 + E 2 injection, 6 h after the P 4 + E 2 treatment, 100 ml sesame oil was injected into the lumen of 1 uterine horn. Twenty hours or 3 d (72 h) later, uterine tissue was collected. Two hours before collection, mice were injected with EdU (2 mg/ml in PBS) to label DNA synthesis. Uterine horns were separated at the cervix and weighed. A piece was fixed in 10% formalin, and the remainder was snap frozen in liquid nitrogen for RNA analysis.
Hormone treatments
Ovariectomized females were injected with E 2 (250 ng in 100 ml saline, i.p., for 24 h or 250 ng in 100 ml sesame oil, s.c., daily for 3 d). For the progesterone switch experiment, ovariectomized females were injected with E 2 daily for 2 d (100 ng in 100 ml sesame oil, s.c.). They rested for 3 d and then injected with P 4 (1 mg in 100 ml sesame oil, s.c., for 3 d and with P 4 or P 4 + 100 ng/ml E 2 on the fourth day). Tissue was collected 18 h later. For 24-h E 2 treatments and the progesterone switch experiment, mice were injected with EdU 2 h before tissues were collected. Luminal epithelial cell heights were measured on hematoxylin and eosin-stained sections using the measurement tool of the ImageJ software package (National Institutes of Health, Bethesda, MD, USA; https://imagej.nih.gov/ij/) by placing 3 markers of cell layer height in 5 different areas per section.
Decidualization of primary hESC culture
Endometrial stromal cells were isolated from proliferative phase endometrial biopsies obtained from healthy volunteers of reproductive age with regular menstrual cycles and no history of gynecologic malignancy, according to a human subjects protocol approved by the Institutional Review Board of the National Institute of Environmental Health Sciences and cultured and transfected with small interfering RNAs (siRNAs) (On-TargetPlus SmartPool; Dharmacon, Lafayette, CO, USA) targeting NELF-B (siNELF-B) or NELF-E (siNELF-E) or with a nontargeting control (siNT) as previously described (13) . Cells were treated with vehicle (V treatment) or 10 nM E 2 (E1024; MilliporeSigma, Burlington, MA, USA), 1 mM medroxyprogesterone acetate (M1629; MilliporeSigma), and 100 mM 2'-O-dibutyryladenosine-39, cAMP (D0627; MilliporeSigma) to induce decidualization [E 2 + P 4 + cAMP (EPC) treatment].
RT-PCR
RNA and cDNA were prepared from mouse uterine tissue as previously described (14) . RNA was prepared from cultured mouse stromal cells or hESCs using 1 ml Trizol reagent (Thermo Fisher Scientific, Waltham, MA, USA) with 250 mg/ml glycogen (MilliporeSigma) and used to synthesize cDNA as previously described (14) . Mouse uterine cDNA was diluted 1:100, and hESC was diluted 1:10 for PCR analysis. Values were calculated relative to the control sample described in each figure; mouse uterine samples were normalized to Rpl7, and hESC was normalized to GAPDH. Sequences of primers are listed in Table 1 .
Immunohistochemistry and EdU detection
Uterine tissue was embedded in paraffin and sectioned (4 mM) onto charged slides. Ki67 (550609; BD Pharmingen/BD Biosciences, San Jose, CA, USA) was detected as previously described (14) , except blocking solution 10% normal horse serum (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) with 1% bovine serum albumin (MilliporeSigma) and 1% Blotto (Santa Cruz Biotechnology, Dallas, TX, USA) was used in place of 10% horse serum. EdU was detected using the Click-iT Kit (Thermo Fisher Scientific). NELF-B (ab16740, Rabbit Anti-Human Cobra1 pAb; Abcam, Cambridge, MA, USA) and NELF-E (10705-1-AP, Rabbit Anti-Human RDBP pAb; Proteintech Group, Chicago, IL, USA) were detected after sections were deparaffinized and then decloaked in a Biocare Decloaking Chamber with Biocare Antigen Decloaking Buffer (Biocare Medical, Pacheco, CA, USA) and blocked with 5% H 2 O 2 . Sections were blocked with blocking solution (10% normal goat serum; Jackson ImmunoResearch Laboratories) with 1% bovine serum albumin (MilliporeSigma) and 1% Blotto (Santa Cruz Biotechnology) and then incubated with antibody diluted in blocking solution (NELF-B 1:50; NELF-E 1:200). Subsequently, antibody was localized with biotinyl-anti-rabbit IgG (Vector Laboratories, Burlingame, CA, USA) and extravidin peroxidase (MilliporeSigma) and Dako Products DAB (Agilent Technologies, Santa Clara, CA, USA). For detection of NELF-B on cytospins, a similar method was used, beginning at the decloaking step. For quantification, the Cell Count tool in ImageJ was used to count 100-200 luminal epithelial or stromal cells in a uterine section, and then to identify and count Ki67-or EdU-positive cells among those counted to calculate the percentage of positive cells.
Culture of mouse uterine stroma cells
Females were mated overnight with B6D2F1/J males, and uterine tissue was collected in the afternoon from 4 dpc females (morning of plug detection = 0.5 dpc), slit longitudinally, minced into 3-to 5-mm pieces, and washed several times with HBSS (MilliporeSigma). Uteri (2 to 3 each) were then placed in a 50-ml tube with 5 ml of 6 mg/ml dispase (Thermo Fisher Scientific) and 25 mg/ml pancreatin (MilliporeSigma) made in HBSS. Tissue was incubated for 60 min on ice, followed by 60 min at room temperature and then 10 min at 37°C. HBSS (30 ml) with 10% FBS was added to each tube. Tissue was washed 2 times with 10 ml HBSS and moved to a 50-ml tube containing 0.5 mg/ml collagenase (MilliporeSigma) and incubated for 45 min at 37°C. Tubes were vortexed until turbid. HBSS (30 ml) + 10% FBS was added, and the suspension passed through a 70-mM filter (MACS Smart Strainer; Miltenyi Biotec, Auburn, CA, USA). Cells were collected by centrifuging at 450 g for 10 min and washed twice in 10 ml HBSS, then resuspended in DMEM-F12 (Thermo Fisher Scientific) containing 10% heat-inactivated fetal calf serum. Cells (400,000) in 3 ml of media were seeded per well of a 6-well plate and allowed to attach for 1 to 2 h. Wells were then washed several times with HBSS to remove nonadherent cells, and fresh DMEM-F12 containing 2% stripped fetal calf serum supplemented with P (1 mM) and E (10 nM) (PE, decidual stimulus) or ethanol [vehicle (V)] was added. After 3 d, cells were collected with Trizol for RNA isolation for RT-PCR, or were trypsinized and collected on cytospins for immunohistochemistry, or were collected using protein lysis buffer for Western blots.
Western blots
Protein was isolated from whole uteri or from cultured mouse or human uterine stromal cells by homogenizing with a protein extraction buffer [50 mM Tris, pH 7.5; 150 mM NaCl; 1% Triton X-100; and 2.5 mg/ml deoxycholate containing aprotinin (20 mg/ml), leupeptin (20 mg/ml), PMSF (4 mg/ml), and phosphatse inhibitors 2 and 3, all from MilliporeSigma]. Pierce BCA assay was used to quantify proteins, which were separated on Nupage BisTris gels with MOPS running buffer (Thermo Fisher Scientific) and transferred to nitrocellulose membranes using the iBlot apparatus (Thermo Fisher Scientific). NELF-B (ab16740 1:500; Abcam), NELF-E (10705-1-AP 1:1000; Proteintech), and bActin (1616R 1:5000; Santa Cruz Biotechnology) proteins were detected after blocking in TBST (20 mM Tris, 140 mM NaCl, and 0.1% TWEEN 20) containing 5% Blotto (Santa Cruz Biotechnology) and probing with primary antibodies, followed by near infrared labeled secondary antibodies (Li-Cor Biosciences, Lincoln, NE, USA), and detected using the Li-Cor Fc instrument with Image Studio software (v.5.2; Li-Cor Biosciences).
Evaluation of allele deletion
DNA was prepared from uterine tissue using the DNAEasy Kit (Qiagen, Germantown, MD, USA) and tested using primers that detect the loxP site that is deleted by Cre excision (LoxP 59 F2, LoxP 59 R) relative to a region of DNA outside the Nelfb locus (Igf ERE2).
Microarray
Cultured mouse uterine stromal cells were collected 24 h after hormone treatment, and RNA was isolated as described above and submitted to the National Institute of Environmental Health Sciences Microarray Core Facility (Bethesda, MD, USA) and analyzed on the Affymetrix MTA Array (Thermo Fisher Scientific) with Transcriptome Analysis Console (TAC) software (Thermo Fisher Scientific.
RESULTS
To evaluate potential biologic roles for transcriptional pausing in endometrial function, negative elongation factor B (NELF-B), a subunit of the 4-subunit NELF complex, was deleted using Pgr-Cre, which results in deletion of Exons 1-4 of Nelfb. Studies in cell culture models have indicated that knockdown or deletion of 1 NELF subunit can destabilize the other NELF subunits by making them vulnerable to proteolysis (15) (16) (17) . Therefore, we evaluated the presence of both the NELF-B and NELF-E subunits in WT and NELF-B Uterine KO. NELF-B and NELF-E were detected throughout the endometrial tissue of the WT uterus (Supplemental Fig. S1A ), in myometrial cells (outer layers), epithelial cells (lining the uterine lumen and glands), and stromal cells (between myometrial and stromal layers). Crossing the NELF-B f/f with PgrCre to generate NELF-B UtcKO decreased NELF-B and NELF-E in most mouse uterine cells. NELF-B and NELF-E were deleted in most stromal cells, with remaining NELF in epithelial cells (Supplemental Fig. S1A ). Western blotting of uterine proteins, using the same NELF-B antibody that was used for IHC and binds to the N terminus of the NELF-B protein (Fig. 1A) , revealed an NELF-B signal that 
is 16% of the amount seen in WT. The amount of undeleted Nelfb allele detected in uterine DNA was significantly decreased in NELF-B UtcKO (Supplemental Fig. S1B ).
We evaluated the fertility of the NELF-B UtcKO females by mating them with fertile males for 6 mo. WT females delivered an average of 4.4 litters with 6.05 pups per litter, whereas NELF-B UtcKO females did not deliver any ( Table 2) . Uterine tissue was collected and examined at the end of the 6-mo mating trial, and NELF-B UtcKO tissue appeared abnormal both grossly and histologically ( Fig. S2B ). Because Pgrdriven Cre activity also occurs in the adult ovary granulosa cells (11) , and NELF-B is detected in ovarian cells (data not presented), ovary function was evaluated. Vaginal cytology of estrous cyclicity and superovulation of adult (26-wk-old) NELF-B UtcKO were assessed, and both were found to be comparable with those of WT littermates (Supplemental Fig. S3 ).
Endometrial response to ovarian hormones is critical for successful pregnancy (6) . Uterine tissue responses to E 2 or P 4 were next evaluated using 2 bioassays that allow evaluation of responses intrinsic to the uterine tissue separate from pregnancy. First, ovariectomized mice were treated with a single E 2 injection, and uterine tissue was evaluated 24 h later for indications of growth responses. Alternatively, E 2 was administered daily for 3 d and uterine tissue collected on the fourth day. E 2 induced uterine growth, as evidenced by increased weight after 24 or 72 h ( Fig. S4B ). E 2 increased uterine weights of NELF-B UtcKO, but uteri were significantly smaller than WT controls (Fig. 1C) . Following E 2 treatments for 24 h, not all of the NELF-B UtcKO epithelial cells expressed Ki67 or showed EdU incorporation, leading to an overall lower percentage of luminal epithelial cells that were positive for the DNA synthesis incorporation indicator, EdU ( Fig. 1D and Supplemental Fig. 4B ). Another measure of mouse endometrial response to E 2 is the height of the luminal epithelium. After 72 h of E 2 treatment, WT uteri display a significantly greater increase in luminal epithelial cell height than NELF-B UtcKO (Supplemental Fig. S4A ). Overall, NELF-B UtcKO respond appropriately to E 2 , but have a blunted growth response (epithelial cell hypertrophy and hypoplasia). Evaluation of Mad2l1, Ltf, and Ramp3, which are established E 2 -responsive uterine transcripts, by real-time PCR revealed no difference between WT and NELF-B UtcKO responses (Supplemental Fig. S4C ). Ltf is selectively induced in epithelial cells (18) , and Ramp3 in stromal cells (19) , indicating both cell types are responding to E 2 .
Uterine PGR is primarily restricted to the epithelial cells of ovariectomized mice, and E 2 decreases epithelial PGR and increases stromal PGR, allowing stromal cell to respond to rising postovulatory P 4 and nidatory E 2 (6) . Mitosis of stromal cells and inhibition of epithelial cell proliferation are critical to embryonic implantation. Treating ovariectomized females with a course of E 2 and P 4 injections that mimics the implantation window leads to stromal cell proliferation, as reflected by EdU incorporation and Ki67-positive cells (Supplemental Fig. S5 ). Following this treatment, some NELF-B UtcKO uteri fail to respond appropriately, exhibit stromal cell response before E 2 treatment, and fail to inhibit epithelial cell proliferation (Supplemental Fig. S5 ).
Stromal cell proliferation is critical to the decidual response, in which the stromal cells expand and differentiate into polyploid decidual cells during endometrial remodeling to support the implanting embryo, placenta formation, and establishment of blood supply (6) . To directly evaluate the stromal cell response, we simulated artificial decidualization by treating ovariectomized females with E 2 and P 4 to mimic ovulation and implantation profiles and injecting inert oil into the lumen of 1 uterine horn to mimic interaction with embryos.
Examining responses 20 h after intraluminal oil infusion reveals an increased weight of the oil-infused uterine horn ( Fig. 2A) , independent of the presence of NELF-B. This suggests that the initial stromal cell response to the decidual stimulus was not disrupted by NELF-B deletion. Both NELF-B and NELF-E are detected throughout the cells of WT uteri (Supplemental Fig. S6 ), and both are decreased in most cells of NELF-B UtcKO uteri and remain in epithelial cells (Supplemental Fig. S6 ). Ki67 and EdU, indicators of stromal cell proliferation, were detected in samples from oil-infused uterine horns, regardless of NELF-B expression ( Fig. 2B and Supplemental Fig. S6 ). Consistent with this observed response, uterine transcripts reflecting cell cycle activity (Cnnb1, Ccnb2, Ccna2, Mad2l1, Cdk1, Mki67) were similarly induced (Fig.  2C ). NELF-B UtcKO uteri are nevertheless significantly smaller than WT ( Fig. 2A) .
Three days after the intraluminal oil infusion, WT uteri exhibited a significant increase in uterine weight (Fig. 3A) when compared with a noninfused horn. In contrast, the NELF-B UtcKO uterus did not respond to the decidualization (Fig. 3A) . Histologically, oil-infused WT uterine tissue shows indications of decidual development, with loss and displacement of luminal epithelia; appearance of large, rounded decidual cells; development of vascular structures; and positive proliferative markers at the margins of the developing decidua ( Fig. 3B and Supplemental Fig. S7 ).
Additionally, both NELF-B and NELF-E are detected in the decidualized WT uteri (Supplemental Fig. 7 ), as well as in NELF-B UtcKO epithelial cells. Oil-infused NELF-B UtcKO uteri appear similar to noninfused controls ( Fig. 3B and Supplemental Fig. S7 ). Uterine RNA was used to assess the induction of decidual markers, Wnt4, Bmp2, and Prl8a2. All 3 were increased in WT oil-infused uterine horns, whereas NELF-B UtcKO uteri lacked a similar response (Fig. 3C ).
Because the initial response of the uterine stromal cells was not impacted by NELF-B deletion, but development of decidual cells required NELF-B, we utilized an in vitro stromal cell culture model to examine responses intrinsic to the decidualizing cells. Stromal cells were isolated from 4 dpc uterine tissue and cultured with P 4 and E 2 to induce decidualization. Both WT and NELF-B UtcKO stroma cells attach and spread within the first day. By d 3 of culture, NELF-B UtcKO cells appear sparse and less elongated (Fig. 4A) . To confirm the enrichment of stromal cells, RNA was evaluated for Des, a marker of stromal cells, and for the epithelial cell marker Krt18; both were detected in patterns indicating enrichment of respective cell populations relative to d 4 uterine tissue (Fig. 4B) . The decidual marker Prl8a2 was induced by PE treatment in WT stromal cells (Fig.  4B) . Interestingly, although decidualization failed to progress in the whole uterus, Prl8a2 was very highly expressed in the absence of NELF-B in isolated stromal cells (Fig. 4B) . Additionally, the basal level of expression of Prl8a2 was greater than the induced level in the WT cells. Evaluation of Nelfb transcript (Fig. 4B ) revealed its reduction in the NELF-B UtcKO cells; additionally, NELF-B protein was decreased in cultured NELF-B UtcKO stromal cells (Supplemental Fig. S8 ). Next, we analyzed RNA from the d 1 decidualized cells by microarray. The differentially expressed genes [.2fold, false discovery rate (FDR) , 0.05] were evaluated for enrichment of pathways ( Table 3) . Consistent with the observed morphologic differences, extracellular matrix (ECM) receptor interaction was significantly enriched. Col11a1 and Lama4 were decreased and Mmp19 and Itgb2 were increased in NELF-B UtcKO uterine stromal cells (Fig. 5) . MMPs are involved in remodeling ECM (20) , and laminins interact with collagen in the ECM and integrins on the cell surface (21) ; thus the changes in their levels may impact the ability of the NELF-B-deficient cells to deposit ECM and attain proper morphology.
A second enriched function of interest is steroid biosynthesis. Induction of Hsd11b2 during decidualization of the stromal cells, which inactivates corticosterone, is lost in NELF-B-deficient stromal cells (Fig. 5 ). Hsd11b2 is also linked to prostaglandin synthesis, and other factors in prostaglandin signaling are altered in NELF-B-deficient stromal cells. Edn1, which facilitates arachidonic acid release from phospholipids, and Ptgs2, which synthesizes prostaglandin H 2 , are both increased (Fig. 5 ). Additionally, Egr1, a transcription factor that interferes with decidual progression (22) , is overexpressed in PE-stimulated NELF-B UtcKO cells.
Decidualization of endometrial stromal cells is critical to human fertility and is also driven by hormonal signals. Perturbations in hormone response are linked to diseases including endometriosis and infertility (23) . To evaluate whether our mouse study, which indicated an essential role of NELF in decidualization, was applicable to human uterine function, we utilized a well-characterized in vitro system in which cultured hESCs are treated with EPC to induce their decidualization (23) . Using siRNA to decrease NELF-B did not alter the appearance of decidualized cells; however, siNELF-E-treated cells did not attain the rounded "cobblestone-like" appearance of decidualized cells (Fig. 6A) . Evaluation of expression of decidual markers, prolactin (PRL) and IGFBP1, indicated increased expression following treatment of siNT cells (Fig. 6B ) but significantly blunted levels of induction in siNELF-B or siNELF-E cells (Supplemental Fig. S9A ). Expression of WNT4 was induced by decidualization, and its induction was decreased by siNELF-E (Supplemental Fig. S9A ). NELF-B or NELF-E transcripts were decreased by the decidualization treatment and were further decreased by their respective siRNAs (Supplemental Fig. S9A ). In addition, siNELF-B decreased NELF-B and NELF-E protein to 12% of the amount in siNT samples (Supplemental Fig.  S9B) . Similarly, siNELF-E decreased NELF-E and NELF-B protein to 26-29% of the amount in siNT samples (Supplemental Fig. S9B ). This phenomenon has been previously reported and demonstrates that NELF subunits stabilize each other (24) . BAD transcript was evaluated as an indicator of cell survival to ensure decreasing NELF complex impacted decidual response and not cell viability. BAD transcript was similarly expressed regardless of NELF status (Supplemental Fig. S9A ).
DISCUSSION
Initially, we hypothesized that NELF complex-mediated Pol II transcriptional pausing would impact uterine E 2 responsiveness. However, disruption of NELF-B subunit expression had minimal impact on E 2 response, in terms of transcription. We did observe a small but significant attenuation of uterine growth, which is consistent with observations of impaired growth of NELF-B KO embryonic fibroblast cells (25) . We did note remaining NELF-B and NELF-E protein in uterine epithelial cells. This is unexpected, considering Pgr-driven Cre activity is consistently seen in uterine epithelial cells (11) . The impact of NELF-B deletion on uterine growth was observed following E 2 stimulation (Fig. 1C, D and Supplemental Fig.  S4 ) and also after the initiation of decidual response, in both the oil infused and the nonstimulated horns ( Fig. 2A) .
Although the uterine tissue does show indications of cellular proliferation in both these studies, qualitatively the stromal cells appear fewer in number ( Fig. 2B and Supplemental Fig. S4B ). Disruption of uterine Nelfb leads to female infertility as a result of impaired decidual response. Studies designed to focus on the uterine decidual response of NELF-B UtcKO females indicated an initial response to the hormonal (P 4 and E 2 ) and physical (intraluminal oil) stimuli, suggesting initiation of decidual response does not require NELFmediated activities. Subsequent full development of decidual tissue was lost, suggesting NELF complex is required later in the decidualization process. Therefore, perhaps the role of NELF is in setting up responses to signals needed subsequent to the initial processes that initiate pregnancy. Using cultured mouse and human uterine stromal cells, we confirmed an impact of NELF on the decidual response. However, in the case of the mouse uterine cells, Nelfb deletion led to overexpression, rather than impairment of induction, of the decidual marker Prl8a2. Although this differs from our observations in the whole uterus, it does indicate an alteration of transcriptional control and altered cellular differentiation. Additionally, cultured NELF-B UtcKO mouse stromal cells had altered extracellular matrix components, weakening their attachment to the culture dish. In the mouse, embryos implant on 4.5 dpc; initially stromal cell proliferation occurs, followed by stromal cell transformation into polyploid decidual cells surrounding the implanted embryo at implantation sites, apparent by 6-8 dpc (26, 27) . When we experimentally induce decidualization, the intraluminal oil injection is designed to mimic embryo apposition and attachment to the uterine lumen before implantation (4 dpc). The response we observe 20 h after oil infusion mirrors the proliferation that occurs at 5 dpc; this response still occurred when Nelfb was absent, but the overall size of the uterine tissue was smaller than WT ( Fig. 2A) . Later, 72 h after oil infusion, the weight of the unstimulated horn of the NELF-B UtcKO increased and matched that of the WT (Fig. 3A) . This suggests that NELF-B is not required for the initiation of decidual response, but that the full growth response is delayed. Underdeveloped implantation sites form after transfer of embryos to pseudopregnant NELF-B UtcKO females (data not presented), consistent with initiation of uterine response, and impaired stromal cell growth. NELF-B UtcKO mouse uterine stroma cells cultured outside the organ exhibit enhanced decidual marker expression, suggesting that the NELF complex may control the rate of decidualization. We noted a decrease in both Nelfb and Nelfe transcripts in cultured mouse and hESCs as a result of the decidualization-inducing treatments (PE for mouse cells, EPC for hESCs). This shows that lowering NELF is part of the process leading to decidualization, so that perhaps NELF slows the rate of decidual progression. However, when we further decreased or disrupted NELF using Cre deletion in mouse cells or siRNA in hESCs, decidualization was impaired, which supports a role for NELF in balancing the progression and timing of the decidual processes, highlighting an essential role of transcriptional pausing as a mechanism that impacts optimal reproduction.
To indicate possible underlying effects of NELF disruption that impact uterine stromal cell function, we compared genes impacted in our cultured mouse uterine cells to the Knockdown Atlas of the Nextbio Correlation Engine. The analysis revealed a positive correlation between differentially expressed genes (DEG) in Nelfb KO vs. WT mouse embryonic fibroblast cells. DEG common to both uterine stromal cell and embryonic fibroblast datasets indicate genes that are targets of the NELF complex, with the increased DEG normally repressed by NELF, and decreased DEG being NELF-induced targets. Interestingly, included in DEG that are increased by Nelfb disruption are 4 members of the Histone H1 cluster (Hist1h1c, Hist1h2bc, Hist1h2be, and Hist1h4i) and Brd2, all involved in chromatin structure. In general, cellular differentiation involves extensive chromatin remodeling (28); perhaps, then, alteration in levels of these chromatin structure components could contribute to cessation of decidual differentiation, by interfering with needed chromatin structures following NELF disruption. Also increased is Egr1, a transcription factor that inhibits decidualization of uterine stromal cells (22) , suggesting a role for NELF in controlling the level of EGR1 during the decidual process. Egr1 overexpression in NELF-B UtcKO calls was validated by RT-PCR in mouse uterine stromal cells cultured for 3 d (Fig. 5 ). Conversely, Nelfb disruption decreases expression of Mad2l1, which is involved in cell cycle progression, in both MEFs and uterine stromal cells, consistent with decreases in cell proliferation observed following disruption of NELF. Similarly, several components of the extracellular matrix (Col1a1, Col6a1, Fbn1, P4ha2) are decreased in both embryonic fibroblasts and uterine stromal cells following deletion of Nelfb, consistent with our observation of reduced adherence of uterine stromal cells. In summary, our findings indicate a previously unrevealed role for NELF-dependent transcriptional pausing in endometrial function. Using 2 model systems, we have demonstrated the importance of NELF in coordinating endometrial responses essential for successful reproduction. Because endometrial dysfunctions underlie conditions including endometriosis, endometrial cancer, and infertility, which impact women's health, our findings revealing a role for transcriptional pausing in endometrial function have the potential to advance our mechanistic understanding of these pathologies.
